Form D · Other
Blue Fever, Inc.
Los Angeles, CA · CIK 0001716505
Offering snapshot reported Jun 17, 2022 · SEC filing
- Reported sold
- $3.03M Offering amount: $5.63M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 3, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 17, 2022 | Initial | $3,030,110 | No comparison | 20 | SEC filing |
| Dec 19, 2018 | Initial | $3,216,916 | No comparison | 0 | SEC filing |
| Sep 11, 2017 | Initial | $60 | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-449602
Source: Form D, filed Jun 17, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joan T. Dea | Director |
| Jonathan Ebinger | Director |
| Greta Mc Anany | Director, Executive |
| Lauren Tracy | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
11630 Chenault Street #9
Los Angeles, CA, 90049
Los Angeles, CA, 90049